Haohai

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

EqualOcean and Skepsos Sign Strategic Cooperation Memorandum of Understanding

On May 20, 2025, Beijing EO Technology Co.,Ltd and the Greater Paris Health Industry Park (Skepsos) officially signed a Memorandum of Understanding on Strategic Cooperation in Beijing.

Under the Fractured Global Supply Chain, How Is United Imaging Shaping a Global "Chain"

Under the Fractured Global Supply Chain, How Is United Imaging Shaping a Global "Chain" Connection?

How Can MedTech Leverage Technological Innovation and Strategic Precision to Go-Global

How Can MedTech Companies Leverage Technological Innovation and Strategic Precision to Expand Globally? | Highlights from GGF2024

With UBS as Bookrunner, Haohai Biotech Goes Public on Star Market

The firm, which is currently listed in Hong Kong, has priced its Shanghai IPO at CNY 89.23 (USD 12.62) a share – the highest listing price on the new sci-tech board to date.